Can Aripiprazole (Abilify) and Bupropion (Wellbutrin) Be Used Together?
Yes, aripiprazole and bupropion can be safely used together, and this combination is specifically supported for treatment-resistant depression, with aripiprazole augmentation of antidepressants (including bupropion) showing superior efficacy compared to switching strategies alone.
Evidence for Combined Use
The combination of aripiprazole with bupropion has established clinical support. In treatment-resistant depression, aripiprazole augmentation of existing antidepressants demonstrated significant improvement in well-being scores and achieved remission rates of 28.9% in older adults 1. Research specifically examining aripiprazole added to bupropion showed rapid improvement in depressive symptoms within the first 1-2 weeks, with sustained benefits over 4+ months 2. A large 52-week safety study found no unexpected adverse events when combining these medications 3.
For patients with major depressive disorder who have inadequate response to bupropion monotherapy, adding aripiprazole 2.5-10 mg/day is the preferred strategy over switching to another antidepressant 1, 4.
Dosing Recommendations
Starting Aripiprazole with Bupropion
- Start aripiprazole at 2.5 mg daily (not 10 mg) to minimize akathisia risk
- Increase by 2.5 mg increments weekly as tolerated
- Target maintenance dose: 5-10 mg daily
- Maximum dose: 15 mg daily (though doses above 5 mg show diminishing returns) 5
The lower starting dose is critical—studies show 50% reduction in discontinuation due to akathisia when starting at 2.5 mg versus 10 mg 6.
Bupropion Dosing
Continue existing bupropion regimen:
- Standard dose: 150 mg twice daily (maximum 300 mg/day) 7
- Can be given as sustained-release or extended-release formulation
- Take second dose before 3 PM to minimize insomnia 8
Key Safety Considerations
Seizure Risk (Most Important)
Bupropion lowers seizure threshold and is contraindicated in patients with:
- Active seizure disorder
- Brain metastases or structural brain lesions
- History of bulimia or anorexia nervosa
- Abrupt alcohol or benzodiazepine withdrawal 7, 9
The seizure risk with bupropion is approximately 0.1% at recommended doses 7. Aripiprazole does not significantly affect seizure threshold but should be used cautiously in patients with seizure history 10.
Akathisia and Movement Disorders
Akathisia is the most common side effect of aripiprazole (8-13% incidence) 10. When combined with bupropion:
- Monitor closely in first 2 weeks
- Reduce aripiprazole dose if akathisia develops
- Consider propranolol 10-20 mg TID for symptomatic management
- Akathisia typically responds to dose reduction 2, 6
Metabolic Effects
Aripiprazole causes less metabolic disruption than other antipsychotics but monitor:
- Weight gain: Mean +2.4 to +3.1 kg over 52 weeks 3
- Fasting glucose: 8-17% develop potentially clinically relevant abnormalities 3
- Lipids: 25-35% develop abnormal fasting cholesterol 3
Bupropion is weight-neutral or causes modest weight loss, partially offsetting aripiprazole's effects.
Drug Interactions
Bupropion is a strong CYP2D6 inhibitor 9. When combined with aripiprazole:
- No dose adjustment of aripiprazole needed (aripiprazole is metabolized by CYP3A4 and CYP2D6, but the interaction is not clinically significant)
- Be cautious with other CYP2D6 substrates (SSRIs, beta-blockers, antipsychotics) 9
Contraindicated combinations:
- MAO inhibitors (must wait 14 days after MAOI discontinuation) 11, 9
- Do not combine with other medications that lower seizure threshold
Neuropsychiatric Monitoring
Both medications carry black box warnings for suicidal ideation in young adults. However:
- Large trials show no increased neuropsychiatric adverse events with bupropion 7
- Naltrexone/bupropion combination studies showed depression rates of 1.3% (similar to placebo) 11
- Monitor for mood changes, especially in first 4-8 weeks
- Bupropion may actually improve depression when combined with aripiprazole 12, 13
Clinical Scenarios
Treatment-Resistant Depression
Primary indication for this combination. After inadequate response to bupropion alone for 8+ weeks, add aripiprazole 2.5 mg daily, titrating to 5-10 mg daily 6, 1.
Bipolar Depression with Comorbid Substance Use
The combination of aripiprazole + mood stabilizer + bupropion showed efficacy in bipolar I depression with cocaine dependence, without triggering mania 13. However, monitor Young Mania Rating Scale scores closely.
Smoking Cessation in Psychiatric Patients
Bupropion is FDA-approved for smoking cessation. The combination can be used safely in patients on aripiprazole for psychiatric conditions 14. Historical concerns about bupropion's pro-dopaminergic effects leading to psychosis are not supported by evidence 14.
Monitoring Schedule
Week 1-2: Assess for akathisia, insomnia, activation Week 4: Evaluate response, adjust aripiprazole dose Week 8-12: Assess remission status; if <5% improvement in depression scores, consider alternative strategy Ongoing: Monitor weight, metabolic parameters (glucose, lipids) every 3-6 months
Common Pitfalls to Avoid
- Starting aripiprazole at 10 mg—this doubles the akathisia-related discontinuation rate
- Giving bupropion late in the day—causes insomnia
- Using in patients with eating disorders—absolute contraindication due to seizure risk
- Failing to monitor for metabolic effects—both medications affect weight and metabolism
- Combining with MAOIs—wait 14 days minimum
- Ignoring seizure risk factors—carefully screen history before prescribing bupropion
When to Discontinue
Stop the combination if:
- Seizure occurs (discontinue bupropion permanently)
- Intolerable akathisia despite dose reduction
- No improvement after 12 weeks at therapeutic doses
- Development of serious neuropsychiatric symptoms
- Patient requires opioid therapy (aripiprazole contains no opioid antagonist, unlike naltrexone/bupropion combinations)